SCHEMBL22944331

SCHEMBL22944331

CC(C)(C)OC(=O)N1CCCC(c2ccc(Oc3ccccc3)cc2)C1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
LMNA P02545 1/20 0.53
HPGD P15428 1/20 0.53
HIF1A Q16665 1/20 0.53
PARP14 Q460N5 2/20 0.53
PARP10 Q53GL7 2/20 0.53
HPGDS O60760 1/20 0.51
PRMT5 O14744 2/20 0.50
USP30 Q70CQ3 2/20 0.49
MAPK1 P28482 1/20 0.49
BTK Q06187 1/20 0.49
PDE4B Q07343 1/20 0.48
NAMPT P43490 1/20 0.47
GPR119 Q8TDV5 1/20 0.47
HSD11B1 P28845 1/20 0.46
BCL9 O00512 2/20 0.46
CTNNB1 P35222 2/20 0.46
KDM1A O60341 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6359096 0.90 ALDH1A1 (0.56) ALDH1A1LMNAHPGDHIF1AHPGDS
SCHEMBL21425202 0.90 BCL9 (0.56) ALDH1A1LMNAHPGDHIF1APARP14
SCHEMBL22944633 0.88 USP30 (0.59) ALDH1A1LMNAHPGDHIF1AHPGDS
SCHEMBL31616130 0.86 NAMPT (0.61) ALDH1A1PARP14PARP10HPGDSUSP30
SCHEMBL19230423 0.86 PRMT5 (0.44) ALDH1A1LMNAHPGDHIF1APARP14
SCHEMBL1935816 0.84 HSD11B1 (0.61) ALDH1A1LMNAHPGDHIF1AHPGDS
SCHEMBL28301552 0.84 PDE4B (0.53) ALDH1A1LMNAHPGDHIF1AHPGDS
SCHEMBL20748135 0.84 PDE4B (0.53) ALDH1A1LMNAHPGDHIF1AHPGDS
SCHEMBL18509294 0.84 GPR119 (0.54) ALDH1A1LMNAHPGDSPDE4BGPR119
SCHEMBL23951735 0.83 TP53 (0.59) ALDH1A1LMNAHPGDHPGDSUSP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11345679-B2 Quaternary lactam compound and pharmaceutical use thereof SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO., LTD. (CN) 2022-05-31 US disclosed
EP-3778588-A1 QUATERNARY LACTAM COMPOUND AND PHARMACEUTICAL USE THEREOF Shanghai Meiyue Biotech Development Co., Ltd. (CN) 2021-02-17 EP disclosed
US-20210032219-A1 QUATERNARY LACTAM COMPOUND AND PHARMACEUTICAL USE THEREOF SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO., LTD. (CN) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210032219-A1 QUATERNARY LACTAM COMPOUND AND PHARMACEUTICAL USE THEREOF F2, PCSK9, F9 ALDH1A1 1831/4885LMNA 2545/4885HPGD 1178/4885
US-11345679-B2 Quaternary lactam compound and pharmaceutical use thereof F2, PCSK9, F9 ALDH1A1 1831/4885LMNA 2545/4885HPGD 1178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.